We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Microvast
MVST
$267M
| – | – |
-157,853
| Closed | -$286K |
|
1002
MaxLinear
MXL
$5.88B
| – | – |
-33,532
| Closed | -$1.09M |
|
1003
Northeast Bank
NBN
$1.14B
| – | – |
-14,348
| Closed | -$526K |
|
1004
Noble Corp
NE
$6.88B
| – | – |
-26,445
| Closed | -$782K |
|
1005
Nike
NKE
$62.5B
| – | – |
-26,515
| Closed | -$2.2M |
|
1006
ServiceNow
NOW
$109B
| – | – |
-46,490
| Closed | -$3.51M |
|
1007
Ocular Therapeutix
OCUL
$1.89B
| – | – |
-100,809
| Closed | -$418K |
|
1008
Oil-Dri
ODC
$1.43B
| – | – |
-51,014
| Closed | -$617K |
|
1009
Oil States International
OIS
$512M
| – | – |
-106,939
| Closed | -$416K |
|
1010
OneMain Financial
OMF
$7.08B
| – | – |
-89,299
| Closed | -$2.64M |
|
1011
Old National Bancorp
ONB
$10.1B
| – | – |
-57,975
| Closed | -$955K |
|
1012
Oportun Financial
OPRT
$262M
| – | – |
-33,787
| Closed | -$148K |
|
1013
Oppenheimer Holdings
OPY
$1.18B
| – | – |
-9,588
| Closed | -$297K |
|
1014
Oric Pharmaceuticals
ORIC
$1.24B
| – | – |
-24,134
| Closed | -$77K |
|
1015
Owlet
OWLT
$152M
| – | – |
-2,152
| Closed | -$32K |
|
1016
PDS Biotechnology
PDSB
$38.7M
| – | – |
-57,651
| Closed | -$171K |
|
1017
Precigen
PGEN
$1.93B
| – | – |
-234,400
| Closed | -$497K |
|
1018
Planet Fitness
PLNT
$4.29B
| – | – |
-3,829
| Closed | -$221K |
|
1019
Palantir
PLTR
$315B
| – | – |
-42,211
| Closed | -$343K |
|
|
PMT
1020
PennyMac Mortgage Investment
PMT
$839M
| – | – |
-32,348
| Closed | -$381K |
|
1021
Protolabs
PRLB
$1.85B
| – | – |
-7,947
| Closed | -$290K |
|
1022
Qualcomm
QCOM
$179B
| – | – |
-2,435
| Closed | -$275K |
|
1023
Quince Therapeutics
QNCX
$17.5M
| – | – |
-2,445
| Closed | -$650K |
|
1024
Rani Therapeutics
RANI
$91M
| – | – |
-18,712
| Closed | -$179K |
|
1025
Ralph Lauren
RL
$22.6B
| – | – |
-7,374
| Closed | -$626K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.